Abstract
Nineteen hypercholesterolemic patients (10 without and 9 with hypertriglyceridemia) were given evening primrose oil rich in gammalinolenic acid (GLA, 18: 3n - 6), in a placebo controlled cross-over design, over 16 weeks (8 + 8 weeks), with safflower oil as the placebo. During supplementation with evening primrose oil, dihomogammalinolenic acid (20: 3n - 6) increased in plasma lipids and red blood cells, and in subjects without hypertriglyceridemia there was a significant decrease in low density lipoprotein-cholesterol and plasma apolipoprotein B compared with the levels observed during safflower oil administration. Our results confirmed that evening primrose oil is effective in lowering low density lipoprotein in hypercholesterolemic patients.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
MeSH terms
-
Adult
-
Apolipoproteins / blood*
-
Cholesterol / blood
-
Dietary Fats, Unsaturated / pharmacology*
-
Double-Blind Method
-
Fatty Acids, Essential / pharmacology
-
Female
-
Humans
-
Hypercholesterolemia / blood*
-
Hypercholesterolemia / diet therapy
-
Linoleic Acids
-
Linolenic Acids / pharmacology*
-
Lipoproteins / blood*
-
Male
-
Middle Aged
-
Oenothera biennis
-
Phospholipids / blood
-
Plant Oils
-
Random Allocation
-
Safflower Oil / pharmacology
-
Triglycerides / blood
-
gamma-Linolenic Acid
Substances
-
Apolipoproteins
-
Dietary Fats, Unsaturated
-
Fatty Acids, Essential
-
Linoleic Acids
-
Linolenic Acids
-
Lipoproteins
-
Phospholipids
-
Plant Oils
-
Triglycerides
-
evening primrose oil
-
gamma-Linolenic Acid
-
Safflower Oil
-
Cholesterol